On Tuesday, April 24, 2018, Evan Boswell, senior principal scientist at Pfizer CentreOne Contract Manufacturing, Pfizer CentreOne will give a presentation on scaling up the manufacturing process of active pharmaceutical ingredients at CPhI North America in Philadelphia, PA.
Pfizer CentreOne Contract Manufacturing Senior Principal Scientist Evan Boswell will present an insight briefing presentation on scaling up the manufacturing process of active pharmaceutical ingredients (APIs) at CPhI North America in Philadelphia, PA, on Tuesday, April 24, 2018.
The presentation will highlight case studies that show how process optimization, using scientific approaches, and economic calculations can significantly cut API manufacturing time and cost. Additionally, Boswell will discuss how to apply a quality-by-design approach to reduce risk.
For more information, visit www.cphinorthamerica.com.
Source: CPhI North America
Tokyo University of Science Research Team Explores Improved Delivery of Antisense Oligonucleotides
April 18th 2025Using cholesterol-modified oligonucleotides, the research team aims to improve the delivery of antisense nucleotide-based therapies for treating neurodegenerative diseases and brain cancers.
Teva and Samsung Bioepis Launch Biosimilar Eculizumab in US Market
April 17th 2025Eculizumab-aagh (EPYSQLI) is now available in the US to treat patients living with difficult-to-treat rare diseases such as paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and generalized myasthenia gravis.